Defining the clinical role of topiramate in the treatment of alcohol dependence in Australia [ 2016 - 2020 ]

Research Grant

Researchers: Prof Paul Haber (Principal investigator) ,  A/Pr Kirsten Morley ,  Dr Marian Shanahan ,  Prof Andrew Baillie ,  Prof Maree Teesson
View all 6 related researchers

Brief description We urgently require new strategies for the treatment of alcohol dependence. The effectiveness of currently approved alcohol medications is limited. Emerging data suggests that topiramate has robust effectiveness and that better medicine selection is possible for patients based on their genotype. We propose to conduct a double-blind randomised controlled trial to examine the clinical and cost effectiveness of topiramate using a genetically based personalised approach.

Funding Amount $AUD 744,959.27

Funding Scheme Project Grants

Notes Standard Project Grant